Literature DB >> 25687908

Can oncology recapitulate paleontology? Lessons from species extinctions.

Viola Walther1, Crispin T Hiley2, Darryl Shibata3, Charles Swanton2, Paul E Turner4, Carlo C Maley5.   

Abstract

Although we can treat cancers with cytotoxic chemotherapies, target them with molecules that inhibit oncogenic drivers, and induce substantial cell death with radiation, local and metastatic tumours recur, resulting in extensive morbidity and mortality. Indeed, driving a tumour to extinction is difficult. Geographically dispersed species of organisms are perhaps equally resistant to extinction, but >99.9% of species that have ever existed on this planet have become extinct. By contrast, we are nowhere near that level of success in cancer therapy. The phenomena are broadly analogous--in both cases, a genetically diverse population mutates and evolves through natural selection. The goal of cancer therapy is to cause cancer cell population extinction, or at least to limit any further increase in population size, to prevent the tumour burden from overwhelming the patient. However, despite available treatments, complete responses are rare, and partial responses are limited in duration. Many patients eventually relapse with tumours that evolve from cells that survive therapy. Similarly, species are remarkably resilient to environmental change. Paleontology can show us the conditions that lead to extinction and the characteristics of species that make them resistant to extinction. These lessons could be translated to improve cancer therapy and prognosis.

Entities:  

Mesh:

Year:  2015        PMID: 25687908      PMCID: PMC4569005          DOI: 10.1038/nrclinonc.2015.12

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  131 in total

1.  Anatomical and ecological constraints on Phanerozoic animal diversity in the marine realm.

Authors:  Richard K Bambach; Andrew H Knoll; J John Sepkoski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  The effect of geographic range on extinction risk during background and mass extinction.

Authors:  Jonathan L Payne; Seth Finnegan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

4.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

5.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.

Authors:  J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

Review 6.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

Review 7.  Assessing the causes of late Pleistocene extinctions on the continents.

Authors:  Anthony D Barnosky; Paul L Koch; Robert S Feranec; Scott L Wing; Alan B Shabel
Journal:  Science       Date:  2004-10-01       Impact factor: 47.728

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

10.  Systemic delivery of oncolytic viruses: hopes and hurdles.

Authors:  Mark S Ferguson; Nicholas R Lemoine; Yaohe Wang
Journal:  Adv Virol       Date:  2012-01-31
View more
  14 in total

Review 1.  Characterizing the ecological and evolutionary dynamics of cancer.

Authors:  Nastaran Zahir; Ruping Sun; Daniel Gallahan; Robert A Gatenby; Christina Curtis
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

2.  First Strike-Second Strike Strategies in Metastatic Cancer: Lessons from the Evolutionary Dynamics of Extinction.

Authors:  Robert A Gatenby; Jingsong Zhang; Joel S Brown
Journal:  Cancer Res       Date:  2019-06-20       Impact factor: 12.701

Review 3.  Spatial Heterogeneity in the Tumor Microenvironment.

Authors:  Yinyin Yuan
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

Review 4.  Tumor evolution: Linear, branching, neutral or punctuated?

Authors:  Alexander Davis; Ruli Gao; Nicholas Navin
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-01-19       Impact factor: 10.680

Review 5.  Integrating evolutionary dynamics into cancer therapy.

Authors:  Robert A Gatenby; Joel S Brown
Journal:  Nat Rev Clin Oncol       Date:  2020-07-22       Impact factor: 66.675

6.  When (distant) relatives stay too long: implications for cancer medicine.

Authors:  Diego Chowell; Amy M Boddy; Diego Mallo; Marc Tollis; Carlo C Maley
Journal:  Genome Biol       Date:  2016-02-24       Impact factor: 13.583

Review 7.  Genome management and mismanagement--cell-level opportunities and challenges of whole-genome duplication.

Authors:  Levi Yant; Kirsten Bomblies
Journal:  Genes Dev       Date:  2015-12-01       Impact factor: 11.361

Review 8.  Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors.

Authors:  Gangshi Wang; Lichan Chen; Baofa Yu; Lucas Zellmer; Ningzhi Xu; D Joshua Liao
Journal:  J Cancer       Date:  2016-01-28       Impact factor: 4.207

Review 9.  Resolution of Complex Issues in Genome Regulation and Cancer Requires Non-Linear and Network-Based Thermodynamics.

Authors:  Jekaterina Erenpreisa; Alessandro Giuliani
Journal:  Int J Mol Sci       Date:  2019-12-29       Impact factor: 5.923

10.  Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer.

Authors:  Kevin H Lin; Justine C Rutter; Abigail Xie; Bryann Pardieu; Emily T Winn; Reinaldo Dal Bello; Antoine Forget; Raphael Itzykson; Yeong-Ran Ahn; Ziwei Dai; Raiyan T Sobhan; Gray R Anderson; Katherine R Singleton; Amy E Decker; Peter S Winter; Jason W Locasale; Lorin Crawford; Alexandre Puissant; Kris C Wood
Journal:  Nat Genet       Date:  2020-03-16       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.